We are live on
!
Find out more
Entrada Therapeutics
TRDA
TRDA
97 hedge funds and large institutions have $481M invested in Entrada Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
175% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 8
133% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 18
110% more call options, than puts
Call options by funds: $551K | Put options by funds: $262K
17% more funds holding
Funds holding: 83 → 97 (+14)
14% more capital invested
Capital invested by funds: $423M → $481M (+$58.3M)
1.01% more ownership
Funds ownership: 79.9% → 80.91% (+1%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
97
Holders Change
+14
Holders Change %
+16.87%
% of All Funds
1.39%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
22
Increased
42
Reduced
18
Closed
8
Calls
$551K
Puts
$262K
Net Calls
+$289K
Net Calls Change
+$288K
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$2.55M |
| 2 |
BlackRock
New York
|
+$2.03M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.47M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.35M |
